Initial T-cell activation required for transplant vasculopathy in retransplanted rat cardiac allografts

被引:15
|
作者
Tori, M
Kitagawa-Sakakida, S
Li, ZZ
Izutani, H
Horiguchi, K
Ito, T
Matsuda, H
Shirakura, R
机构
[1] Osaka Univ, Grad Sch Med E9, Biomed Res Ctr, Div Organ Transplantat, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med E9, Dept Surg Funct Regulat, Suita, Osaka 5650871, Japan
关键词
D O I
10.1097/00007890-200009150-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. A precise understanding of immunological mechanisms is needed to prevent transplant vasculopathy, Methods. The developing process of transplant vasculopathy was investigated by retransplanting rat cardiac allografts and measuring the expressions of 21 different genes inside the retransplanted allografts under nonimmunosuppressive conditions. Results. Significant transplant vasculopathy developed if WKY hearts were grafted to LEW and retransplanted to WKY 5 days after the initial grafting, but it did not in allografts retransplanted 3 days after the initial grafting,The disease did not progress in retransplanted isografts or if nude rats were used as the initial recipients. However, the development of transplant vasculopathy was not affected by changing the second recipients to the F1 progeny of donor x recipient or to nude animals. Among the expressions of 21 different genes observed in allografts at 1, 14, 30, or 60 days after retransplantation, those of T-cell activation-related genes, such as interferon-gamma and Fas ligand, showed the earliest and the most dramatic difference between 3- and 5-day-retransplanted allografts whereas macrophage/monocyte activation-related genes showed little difference. Furthermore, reverse transcription-polymerase chain reaction analyses of allografts retransplanted to nude animal indicated that T cells of the initial recipient origin survive and remain activated even 60 days after retransplantation, Conclusions. The T-cell response occurring between 3 and 5 days after grafting was identified as the critical parameter to the disease progression. Once alloreactive T cells enter a graft, they may be able to survive a long period and promote chronic rejection.
引用
收藏
页码:737 / 746
页数:10
相关论文
共 50 条
  • [1] Microarray-based gene expression profiling of retransplanted rat cardiac allografts that develop cardiac allograft vasculopathy
    Kitagawa-Sakakida, S
    Fukushima, N
    Sawa, Y
    Horiguchi, K
    Doi, T
    Shirakura, R
    Matsuda, H
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (12): : 2068 - 2074
  • [2] T-CELL ACTIVATION IN CARDIAC TRANSPLANT RECIPIENTS
    MCKAY, DB
    MILFORD, EL
    CARPENTER, CB
    KARTASHOV, AI
    SCHOEN, FJ
    LOH, E
    ARANKI, SF
    COUPER, GS
    MUDGE, GH
    TRANSPLANTATION, 1994, 58 (02) : 241 - 245
  • [3] MONITORING OF T-CELL SUBPOPULATIONS IN HETEROTOPIC CARDIAC ALLOGRAFTS IN THE RAT
    SHAPIRO, R
    GOLDMAN, MH
    ALLEN, C
    BROWN, J
    CAPEHART, J
    KAWAGUCHI, A
    LOWER, RR
    TRANSPLANTATION PROCEEDINGS, 1984, 16 (06) : 1540 - 1541
  • [4] PROLONGATION OF SURVIVAL OF RAT CARDIAC ALLOGRAFTS BY T-CELL VACCINATION
    SHAPIRA, OM
    MOR, E
    RESHEF, T
    PFEFFERMANN, RA
    COHEN, IR
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (02): : 388 - 390
  • [5] Active cell migration in retransplanted rat cardiac allografts during the course of chronic rejection
    Kitagawa-Sakakida, S
    Tori, M
    Li, ZZ
    Horiguchi, K
    Izutani, H
    Matsuda, H
    Shirakura, R
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (06): : 584 - 590
  • [6] JNK is required for effector T-cell function but not for T-cell activation
    Dong, C
    Yang, DD
    Tournier, C
    Whitmarsh, AJ
    Xu, J
    Davis, RJ
    Flavell, RA
    NATURE, 2000, 405 (6782) : 91 - 94
  • [7] JNK is required for effector T-cell function but not for T-cell activation
    Chen Dong
    Derek D. Yang
    Cathy Tournier
    Alan J. Whitmarsh
    Jie Xu
    Roger J. Davis
    Richard A. Flavell
    Nature, 2000, 405 : 91 - 94
  • [8] Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts
    Simonson, MS
    Herman, WH
    Robinson, A
    Schulak, J
    Hricik, DE
    TRANSPLANTATION, 1999, 67 (12) : 1542 - 1547
  • [9] Dissection of the CMV specific T-cell response is required for optimized cardiac transplant monitoring
    Kirchner, Alexander
    Hoffmeister, Bodo
    Cherepnev-G, Georgy
    Fuhrmann, Stephan
    Streitz, Mathias
    Lachmann, Raskit
    Bunde, Torsten
    Meij, Pauline
    Schoenemann, Constanze
    Hetzer, Roland
    Lehmkuhl, Hans B.
    Volkmer-Engert, Rudolf
    Volk, Hans-Dieter
    Gratama, Jan W.
    Kern, Florian
    JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (09) : 1604 - 1614
  • [10] 2 STIMULI REQUIRED FOR T-CELL ACTIVATION ARE REQUIRED SIMULTANEOUSLY
    WEISS, A
    IMBODEN, J
    MANGER, B
    SHIELDS, R
    CLINICAL RESEARCH, 1986, 34 (02): : A510 - A510